Velufenacin

N/A

Report date: 2024/02/21 12:01:06
NME

Base Information

Drug NameVelufenacin
Drug Alias NameDA-8010
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor M3 antagonists
TargetsMuscarinic acetylcholine receptor M3
Therapy Area/IndicationsUrinary Bladder, OveractiveRenal Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesDong-A ST Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDong-A ST Co Ltd
Inactive CompaniesN/A
Active IndicationsUrinary Bladder, OveractiveRenal Insufficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipedia